Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Tauns Laboratories, Inc. ( (JP:197A) ).
Tauns Laboratories, Inc. has released a financial highlights document for the second quarter of FY2026, covering the period ended December 31, 2025. The release outlines the company’s corporate profile, quarterly financial results, full-year forecast, and recent topics, indicating a structured update to investors and stakeholders on its current performance and future outlook.
The most recent analyst rating on (JP:197A) stock is a Hold with a Yen613.00 price target. To see the full list of analyst forecasts on Tauns Laboratories, Inc. stock, see the JP:197A Stock Forecast page.
More about Tauns Laboratories, Inc.
Tauns Laboratories, Inc. is a diagnostics company operating in the medical and life sciences sector. It is identified by the code 197A and appears to focus on laboratory-related products and services, with financial reporting oriented around fiscal year quarters and forecasts for its operational performance.
Average Trading Volume: 534,574
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen59.59B
Learn more about 197A stock on TipRanks’ Stock Analysis page.